J-Pharma

520A.TTSE GROWTHPharmaceutical
Financials · Standalone
Fiscal year ended2026-032025-032024-032023-032022-03
Operating income−¥3.7bn−¥1.6bn———
Ordinary income−¥2.6bn−¥1.5bn−¥1.6bn−¥1.1bn−¥1.1bn
Total assets¥4.8bn¥2.9bn¥1.2bn¥1.8bn¥1.2bn
Net assets / equity¥4.4bn¥2.4bn¥950m¥1.4bn¥994m
Operating cash flow−¥2.2bn−¥1.7bn−¥1.4bn——
EPS (basic)¥-195.08¥-184.05¥-263.57¥-952.74¥-974.48

From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 1
PeriodFormFiledFigures
2025-04-01 → 2026-03-31Annual2026-06-2492 figures · EDINET